Post by
Wino115 on Feb 16, 2023 11:09am
Interesting committee they've formed
Very interesting group put together for this stage.
- The Yale doctor is the one who trialed docetaxal through all three phases for prostate cancer. So a specialist in what taxols can do. Hopefully he can also tap into that Yale PDC connection. So he might be the chemo bomb expert.
- The Texas doctor (who's Canadian actually) specializes almost exclusively in doing Phase 1 trials for oncology. He also started a cancer genome project, so I assume he might be the expert around the target and sort1, maybe toxicity and safety issues to. Also perhaps dosing logic.
- The Tennesee doctor seems to be a leader in gynecological and overall research, she seems to be a leader in the conferences and has a lot of social media followers. Seems sort of an all around type.
We know the lead investigator is the MD Anderson women along with those other 3-4 clinics and then Rothemberg sheparded 3-4 oncology drugs for Pfizer.
Seems like they have the key bases covered.
Comment by
Trogarzon on Feb 16, 2023 11:29am
Maybe this draws interest from their followers... if they mention it of course on their Twitter accounts or in their Pharma networks maybe some Paul Levesque somewhere picks it up and gives our Paul a call to discuss a partnership... from rags to riches again.... who hoo...
Comment by
palinc2000 on Feb 16, 2023 3:38pm
I do think that this step with a Cimmittee is a necessary step especially given that in house experts is almost non existent.... While I dont hold my breath for a eureka moment I dont see much downside in going thru this exercise .